Literature DB >> 18927451

Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study.

Sol M Rodriguez-Colon1, Jingping Mo, Yinkang Duan, Jiahao Liu, Joanne E Caulfield, Xuejuan Jin, Duanping Liao.   

Abstract

BACKGROUND AND
PURPOSE: Little is known about the metabolic syndrome (MetS) and the risk of incident stroke. This study is designed to identify particular clusters of MetS components that carry the highest risk of incident stroke.
METHODS: We analyzed the public use data from the population-based Atherosclerosis Risk in Communities study. At baseline, 14 993 stroke-free middle-aged individuals were followed-up over 9 years for incident stroke. MetS components were defined according to the National Heart, Lung, and Blood Institute/American Heart Association criteria. Incident stroke was identified using a standardized incident events identification and classification protocol. Proportional hazard models were used to assess the RRs and 95% CIs of ischemic stroke associated with MetS and its different clusters.
RESULTS: At baseline, the prevalence of MetS was 39%. The mean age was 54, with 26% blacks and 55% females. The hazard ratio of incident ischemic stroke associated with MetS among women (hazard ratio, 2.41; 95% CI, 1.69 to 3.49) and men (hazard ratio, 2.11; 95% CI, 1.56-2.85) was similar. There was a dose-response relationship between the numbers of MetS components and the risk of incidence stroke. Persons with either elevated blood pressure or elevated fasting glucose in the clusters to form a MetS had the highest risk for incident stroke (hazard ratio, 2.74-4.16 comparing to the reference group) than MetS without these 2 components (hazard ratio, </=2.00 comparing to the reference group).
CONCLUSIONS: The data support the need to target MetS, especially MetS, with these 2 highest risk components (elevated blood pressure or elevated fasting glucose) in the clusters.

Entities:  

Mesh:

Year:  2008        PMID: 18927451     DOI: 10.1161/STROKEAHA.108.523035

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

1.  Metabolic syndrome and localization of white matter hyperintensities in the elderly population.

Authors:  Florence Portet; Adam M Brickman; Yaakov Stern; Nikolaos Scarmeas; Jordan Muraskin; Frank A Provenzano; Claudine Berr; Alain Bonafé; Sylvaine Artero; Karen Ritchie; Tasnime N Akbaraly
Journal:  Alzheimers Dement       Date:  2012-06-06       Impact factor: 21.566

2.  Revisiting screening for type 2 diabetes mellitus: to screen or not to screen, that is the question.

Authors:  Saleh A Aldasouqi; Ved V Gossain
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

3.  Risk profiles for metabolic syndrome and its transition patterns for the elderly in Beijing, 1992-2009.

Authors:  Li-Xin Tao; Wei Wang; Hui-Ping Zhu; Da Huo; Tao Zhou; Lei Pan; Qi Gao; Yan-Xia Luo; Li-Juan Wu; Xia Li; Zhe Tang; Xiu-Hua Guo
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

4.  Metabolic syndrome burden in apparently healthy adolescents is adversely associated with cardiac autonomic modulation--Penn State Children Cohort.

Authors:  Sol M Rodríguez-Colón; Fan He; Edward O Bixler; Julio Fernandez-Mendoza; Alexandros N Vgontzas; Susan Calhoun; Zhi-Jie Zheng; Duanping Liao
Journal:  Metabolism       Date:  2015-02-03       Impact factor: 8.694

Review 5.  Exercise and Environmental Enrichment as Enablers of Task-Specific Neuroplasticity and Stroke Recovery.

Authors:  Jessica Livingston-Thomas; Paul Nelson; Sudhir Karthikeyan; Sabina Antonescu; Matthew Strider Jeffers; Susan Marzolini; Dale Corbett
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

6.  Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy.

Authors:  Eberhard Wille; Jürgen Scholze; Eduardo Alegria; Claudio Ferri; Sue Langham; Warren Stevens; David Jeffries; Kerstin Uhl-Hochgraeber
Journal:  Eur J Health Econ       Date:  2010-04-20

7.  Impact of metabolic syndrome components on incident stroke subtypes: a Chinese cohort study.

Authors:  Y-C Chen; C-A Sun; T Yang; C-H Chu; C-H Bai; S-L You; L-C Hwang; C-H Chen; C-Y Wei; Y-C Chou
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

8.  Cyclooxygenase-derived vasoconstriction restrains hypoxia-mediated cerebral vasodilation in young adults with metabolic syndrome.

Authors:  John W Harrell; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

9.  Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA.

Authors:  Ajay K Gupta; Bjorn Dahlof; Peter S Sever; Neil R Poulter
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

10.  Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study.

Authors:  Susanne Moebus; Chakrapani Balijepalli; Christian Lösch; Laura Göres; Bernd von Stritzky; Peter Bramlage; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Cardiovasc Diabetol       Date:  2010-08-09       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.